Regulating Medicines in a Globalized World – Nov. 21 Report and Webinar
As drug development becomes more globalized, and the ease of international travel increases the opportunities for disease to cross borders, it is critical that countries’ medicine regulatory authorities (RAs) share information and resources.
A new report from the National Academies of Sciences, Engineering, and Medicine outlines how RAs can rely upon and consult each other’s work to make sound decisions about the review and approval of medicines. The report — Regulating Medicines in a Globalized World: Need for Increased Reliance Among Regulators — also examines how cooperation among RAs can promote more consistent quality, safety, and efficacy standards for medicines globally.
Members of the committee will present the report's findings and recommendations during a webinar at 9 a.m. EST Thursday, Nov. 21.
Advance copies will be available to reporters only starting at noon EST on Wednesday, Nov. 20.
The report is embargoed and not for public release before 9 a.m. EST Thursday, Nov. 21.
Reporters who wish to obtain copies should contact the Office of News and Public Information at tel. 202-334-2138 or e-mail email@example.com.
Office of News and Public Information